Meso Numismatics, Inc. Share Price

Equities

MSSV

US59071L1035

Biotechnology & Medical Research

Market Closed - OTC Markets 11:01:58 31/05/2024 pm IST 5-day change 1st Jan Change
0.0395 USD +0.03% Intraday chart for Meso Numismatics, Inc. +8.82% +441.10%
Sales 2022 1.53M 128M Sales 2023 2.41M 201M Capitalization 91.2K 7.61M
Net income 2022 -5M -417M Net income 2023 -9M -751M EV / Sales 2022 8.97 x
Net Debt 2022 13.5M 1.13B Net Debt 2023 17.12M 1.43B EV / Sales 2023 7.14 x
P/E ratio 2022
-0.04 x
P/E ratio 2023
-0.01 x
Employees 1
Yield 2022 *
-
Yield 2023
-
Free-Float 84.19%
More Fundamentals * Assessed data
Dynamic Chart
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Meso Numismatics, Inc. will Change its Name to Regenerative Medical Technology Group Inc CI
Meso Numismatics, Inc. Announces New Clinics CI
Meso Numismatics, Inc. Reports Sales Results for the Year 2023 CI
Meso Numismatics, Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
Meso Numismatics, Inc. announced that it expects to receive $10 million in funding from GHS Investments, LLC CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Meso Numismatics, Inc. Auditor Raises 'Going Concern' Doubt CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Meso Numismatics, Inc.'s Global Stem Cells Group Announces Launch of New Stem Cells and Regenerative Medicine Clinic in CDMX CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
More news
1 day+0.03%
1 week+8.82%
1 month-18.05%
3 months-6.40%
6 months+381.71%
Current year+441.10%
More quotes
1 week
0.04
Extreme 0.036
0.04
1 month
0.04
Extreme 0.035
0.05
Current year
0.01
Extreme 0.0073
0.06
1 year
0.01
Extreme 0.0072
0.06
3 years
0.01
Extreme 0.0072
0.35
5 years
0.01
Extreme 0.0072
0.35
10 years
0.01
Extreme 0.0072
600.02
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 27/19/27
Members of the board TitleAgeSince
Chief Executive Officer 59 27/19/27
More insiders
Date Price Change Volume
31/24/31 0.0395 +0.03% 19,250
30/24/30 0.0395 +1.26% 5,500
28/24/28 0.039 +7.56% 11,850
24/24/24 0.0363 -20.31% 10,209

Delayed Quote OTC Markets, May 31, 2024 at 11:01 pm IST

More quotes
Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.
More about the company

Annual profits - Rate of surprise